Clinical Trial

Bright Ideas - CIN Feasibility Study

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 31, 2025 (before its estimated June 2025 completion). Its status may not reflect the trial's current state.
Summary
In this study investigators will determine the feasibility of a future trial comparing chemotherapy-induced nausea control in children with ALL receiving oral 6-mercaptopurine who do and do not receive problem-solving skill training. This is a novel approach to controlling an important and common treatment-related symptom.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2021-06-10; most recent amendment 2025-01-28.
Status change: Not Yet Recruiting → Recruiting 2022-07-30
Trial Details
NCT Number NCT04929899
Lead Sponsor The Hospital for Sick Children
Collaborators: Rutgers Cancer Institute of New Jersey, Inova Fairfax Hospital, Children's Hospital Los Angeles
Conditions Acute Lymphoblastic Leukemia (ALL)
Enrollment 75 participants
Start Date 2022-03-01
Primary Completion 2025-06 (estimated)
Study Completion 2025-06 (estimated)
Updated on ClinicalTrials.gov 2025-01-31